Marex Group’s Amgen AMGN Stock Holding History

Marex Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-350,000	Closed	-$115M	–	1018
2025 Q4	$115M	Buy	+350,000	New	+$111M	0.72%	40

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Marex Group's AMGN Position: Q2 2026 in Review

Marex Group increased its Amgen (AMGN) stake by 8,562% in Q2 2026, buying an estimated $66.9M and bringing the position to 197,671 shares worth $71.6M. The position accounts for 0.3% of the portfolio, ranked #75.

Marex Group first reported a position in AMGN in Q4 2022 and has held it in 10 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Marex Group held 197,671 shares of Amgen worth $71.6M as of Q2 2026.
Marex Group bought 195,389 Amgen shares in Q2 2026, an estimated $66.9M.
Amgen made up 0.3% of Marex Group's portfolio in Q2 2026, its #75 holding.
Marex Group first reported a position in Amgen in Q4 2022 and has held it in 10 quarters since.
3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.